Rogaine (for Women)

   
Google
 
Web NewDrugInformation.com

Rogaine (for Women)


Drug - Rogaine (for Women)
The trade name of the product as shown on the labeling.

Dosage - SOLUTION; TOPICAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Minoxidil
Multiple ingredients are in alphabetical order.

Strength - 2%
The potency of the active ingredient(s), Minoxidil. May repeat for multiple part products.

Applicant - PHARMACIA AND UPJOHN
The firm name holding legal responsibility for Rogaine (for Women). The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 019501
The FDA assigned number to Rogaine (for Women). Format is nnnnnn.

Product Number - 003
The FDA assigned number to identify Rogaine (for Women). Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Feb 9, 1996
The date Rogaine (for Women) was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Rogaine (for Women). The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - OTC
The group or category of approved drugs Rogaine (for Women) is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pharmacia And Upjohn Co
The full name of the firm holding legal responsibility for the new application of Rogaine (for Women).

Rogaine (for Women)